GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Catalent Inc (STU:0C8) » Definitions » Net Change in Cash

Catalent (STU:0C8) Net Change in Cash : €116 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Catalent Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Catalent's Net Change in Cash for the three months ended in Sep. 2024 was €41 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was €116 Mil.


Catalent Net Change in Cash Historical Data

The historical data trend for Catalent's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Catalent Net Change in Cash Chart

Catalent Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 539.90 -47.31 -422.86 -155.99 8.36

Catalent Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -66.53 18.34 -61.64 117.98 41.45

Catalent Net Change in Cash Calculation

Catalent's Net Change in Cash for the fiscal year that ended in Jun. 2024 is calculated as

Catalent's Net Change in Cash for the quarter that ended in Sep. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €116 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Catalent Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Catalent's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Catalent Business Description

Traded in Other Exchanges
N/A
Address
14 Schoolhouse Road, Somerset, NJ, USA, 08873
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.

Catalent Headlines

No Headlines